Hyperleukocytosis and leukocytapheresis in acute leukaemias: Experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia

Transfusion Medicine

Volumn 23, Issue 6, 2013, Pages 397-406

  Bruserud, Ø ^a,b   Liseth, K ^b   Stamnesfet, S ^b   Cacic, D L ^b   Melve, G ^b   Kristoffersen, E ^b   Hervig, T ^b   Reikvam, H ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myeloid leukaemia; Hyperleukocytosis; Leukaemia; Leukostasis

Indexed keywords

CLOFARABINE; CYTARABINE; DAUNORUBICIN; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; EARLY INTERVENTION; FEMALE; HUMAN; LEUKAPHERESIS; LEUKEMIA CELL; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE;

ACUTE MYELOID LEUKAEMIA; HYPERLEUKOCYTOSIS; LEUKAEMIA; LEUKOSTASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKAPHERESIS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84888376963     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12067     Document Type: Article

References (31)

1. Abrahamsson, J., Forestier, E., Heldrup, J. et al. (2011) Response-guided induction therapy in pediatric acute myeloid leukaemia with excellent remission rate. Journal of Clinical Oncology, 29, 310-315.
2. Baer, M.R., Stein, R.S. & Dessypris, E.N. (1985) Chronic lymphocytic leukaemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer, 56, 2865-2869.
3. Bruserud, O., Hovland, R., Wergeland, L., Huang, T.S. & Gjertsen, B.T. (2003) Flt3-mediated signaling in human acute myelogenous leukaemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. Haematologica, 88, 416-428.
4. Bug, G., Anargyrou, K., Tonn, T., Bialleck, H., Seifried, E., Hoelzer, D. & Ottmann, O.G. (2007) Impact of leukocytapheresis on early death rate in adult acute myeloid leukaemia presenting with hyperleukocytosis. Transfusion, 47, 1843-1850.
5. Bunin, N.J. & Pui, C.H. (1985) Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukaemia. Journal of Clinical Oncology, 3, 1590-1595.
6. Chang, M.C., Chen, T.Y., Tang, J.L., Lan, Y.J., Chao, T.Y., Chiu, C.F. & Ho, H.T. (2007) Leukocytapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukaemia: no impact on early mortality and intracranial hemorrhage. American Journal of Hematology, 82, 976-980.
7. Chekol, S.S., Bhatnagar, B., Gojo, I. & Hess, J.R. (2012) Leukopheresis for profound hyperleukocytosis. Transfusion and Apheresis Science, 46, 29-31.
8. Cuttner, J., Conjalka, M.S., Reilly, M., Goldberg, J., Reisman, A., Meyer, R.J. & Holland, J.F. (1980) Association of monocytic leukaemia in patients with extreme leukocytosis. The American Journal of Medicine, 69, 555-558.
9. Cuttner, J., Holland, J.F., Norton, L., Ambinder, E., Button, G. & Meyer, R.J. (1983) Therapeutic leukocytapheresis for hyperleukocytosis in acute myelocytic leukaemia. Medical and Pediatrical Oncology, 11, 76-78.
10. De Santis, G.C., de, Oliveira, L.C., Romano, L.G., Almeida Prado Bde, P. Jr., Simoes, B.P., Rego, E.M., Covas, D.T. & Falcao, R.P. (2011) Therapeutic leukocytapheresis in patients with leukostasis secondary to acute myelogenous leukaemia. Journal of Clinical Apheresis, 26, 181-185.
11. Dutcher, J.P., Schiffer, C.A. & Wiernik, P.H. (1987) Hyperleukocytosis in adult acute nonlymphocytic leukaemia: impact on remission rate and duration, and survival. Journal of Clinical Oncology, 5, 1364-1372.
12. Döhner, H., Estey, E.H., Amadori, S. et al. (2010) Diagnosis and management of acute myeloid leukaemia in adults: recommendations from an international expert panel, on behalf of the European LeukaemiaNet. Blood, 115, 453-474.
13. Estey, E.H. (2012) Acute myeloid leukaemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology, 87, 89-99.
14. Giles, F.J., Shen, Y., Kantarjian, H.M. et al. (2001) Leukocytapheresis reduces early mortality in patients with acute myeloid leukaemia with high white cell counts but does not improve long-term survival. Leukaemia & Lymphoma, 42, 67-73.
15. Greenwood, M.J., Seftel, M.D., Richardson, C. et al. (2006) Leukocyte count as a predictor of death during remission induction in acute myeloid leukaemia. Leukaemia & Lymphoma, 47, 1245-1252.
16. Hatfield, K.J., Bedringsaas, S.L., Ryningen, A., Gjertsen, B.T. & Bruserud, O. (2010a) Hypoxia increases HIF-1alpha expression and constitutive cytokine release by primary human acute myeloid leukaemia cells. European Cytokine Network, 21, 154-164.
17. Hatfield, K.J., Reikvam, H. & Bruserud, O. (2010b) The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukaemia. Current Medical Chemistry, 17, 4448-4461.
18. Hoelzer, D., Thiel, E., Loffler, H. et al. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukaemia in adults. Blood, 71, 123-131.
19. Majhail, N.S. & Lichtin, A.E. (2004) Acute leukaemia with a very high leukocyte count: confronting a medical emergency. Cleveland Clinic Journal of Medicine, 71, 633-637.
20. Marbello, L., Ricci, F., Nosari, A.M. et al. (2008) Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leukaemia Research, 32, 1221-1227.
21. Paupert, J., Mansat-De Mas, V., Demur, C., Salles, B. & Muller, C. (2008) Cell-surface MMP-9 regulates the invasive capacity of leukaemia blast cells with monocytic features. Cell Cycle, 7, 1047-1053.
22. Porcu, P., Danielson, C.F., Orazi, A., Heerema, N.A., Gabig, T.G. & McCarthy, L.J. (1997) Therapeutic Leukocytapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. British Journal of Haematology, 98, 433-436.
23. Reikvam, H., Hatfield, K.J., Oyan, A.M., Kalland, K.H., Kittang, A.O. & Bruserud, O. (2010) Primary human acute myelogenous leukaemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. European Journal of Hematology, 84, 239-251.
24. Rodgers, R., Latif, Z. & Copland, M. (2012) How I manage priapism in chronic myeloid leukaemia patients. British Journal of Haematology, 158, 155-164.
25. Rowe, J.M. & Lichtman, M.A. (1984) Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukaemia. Blood, 63, 1230-1234.
26. Sissolak, G., Hoffbrand, A.V., Mehta, A.B. & Ganeshaguru, K. (1993) Interferon-alpha inducible 2'-5' oligoadenylate synthetase transcripts in lymphoid and myeloid leukaemias. Leukaemia, 7, 712-716.
27. Soares, F.A., Landell, G.A. & Cardoso, M.C. (1992) Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases. American Journal of Hematology, 40, 28-32.
28. Szczepiorkowski, Z.M., Winters, J.L., Bandarenko, N. et al. (2010) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. Journal of Clinical Apheresis, 25, 83-177.
29. Thiebaut, A., Thomas, X., Belhabri, A., Anglaret, B. & Archimbaud, E. (2000) Impact of pre-induction therapy leukocytapheresis on treatment outcome in adult acute myelogenous leukaemia presenting with hyperleukocytosis. Annals of Hematology, 79, 501-506.
30. Tsykunova, G., Reikvam, H., Hovland, R. & Bruserud, O. (2012) The surface molecule signature of primary human acute myeloid leukaemia (AML) cells is highly associated with NPM1 mutation status. Leukaemia, 26, 557-559.
31. Wheatley, K., Burnett, A.K., Goldstone, A.H. et al. (1999) A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. British Journal of Haematology, 107, 69-79.